Breathe Well Live Well
|
Teva's Asthma Drug 'Significantly' Improves Lung Function In Phase 3 Trials
NASDAQ (RTTNews.com) – Teva Pharmaceutical Industries Ltd. ( TEVA ) Monday said asthma patients with elevated eosinophils showed significant improvement in lung function and asthma control after being treated with reslizumab in final-stage studies of the anti … |
View full post on asthma – Google News
Globes |
Teva finds positive results in advanced trials for asthma drug
Yahoo News TEL AVIV (Reuters) – Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma. Reslizumab, an … Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies Teva reports positive Phase III asthma drug results |
View full post on asthma – Google News
Globes |
Teva finds positive results in advanced trials for asthma drug
Reuters Reslizumab, an investigational antibody, showed statistically significant reductions in the frequency of asthma exacerbations – episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness – compared to patients … Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies Teva reports positive Phase III asthma drug results |
View full post on asthma – Google News
menifee247 |
Elite Clinical Trials Test Doses of Dulera for Asthma
menifee247 The primary coordinator of the asthma study, clinical research coordinator Stefanie Richardson, says most of patients participating in the study either don't have medical insurance or they simply cannot afford to pay the co-pay for the asthma therapy. |
View full post on asthma – Google News
Headlines & Global News |
Initial Trials Show Promising Drug Treatment for Allergic Asthma
Headlines & Global News "I've never seen anything quite like this," said Paul O'Byrne, the study's lead investigator and chairman of the executive committee of the nonprofit Global Initiative for Asthma. "It's too early to say if it's going be effective in treatment. But if … Amgen, Inc. (NASDAQ:AMGN) Zeroing In On Allergic Asthma Treatment With Big … |
View full post on asthma – Google News
|
Elite Clinical Trials Tests Varying Dulera Doses for Asthma
menifee247 “When the study is over, these patients are able to go to their doctor and inform them that they had fewer asthma symptoms with Dulera and have their PCP prescribe this medication for them [now] versus waiting several years for a medication to be … |
View full post on asthma – Google News
|
Asthma Global Clinical Trials Review, H2, 2013
SBWire (press release) The publisher's clinical trial report, Asthma Global Clinical Trials Review, H2, 2013" provides data on the Asthma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Asthma. It includes an … |
View full post on asthma – Google News
|
Asthma Global Clinical Trials Review, H1, 2013: New Research Report …
SBWire (press release) Boston, MA — (SBWIRE) — 06/15/2013 — GlobalData's clinical trial report, "Asthma Global Clinical Trials Review, H1, 2013" provides data on the Asthma clinical trial scenario. This report provides elemental information and data relating to the … |
View full post on asthma – Google News
|
"Asthma Global Clinical Trials Review, H1, 2012" Now Available at Fast Market …
SBWire (press release) Boston, MA — (SBWIRE) — 07/24/2012 — GlobalData's clinical trial report, "Asthma Global Clinical Trials Review, H1, 2012" provides data on the Asthma clinical trial scenario. This report provides elemental information and data relating to the … |
View full post on asthma – Google News
|
Research and Markets: Asthma Global Clinical Trials Review, H1, 2012
Business Wire (press release) Research and Markets (http://www.researchandmarkets.com/research/bwk37f/asthma_global_clin) has announced the addition of GlobalData's new report &quo. |
View full post on asthma – Google News